| 181/356 | US=65 / Biol/Mol List K, Bugge TH. Physiological and pathological functions of type II transmembrane serine proteases: lessons from transgenic mouse models and human disease-associated mutations. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 259-79. ISBN 978-0-387-69056-8. SERINAPROTEASES TRANSMEMBRANA TIPO II; FUNCOES FISIOLOGICAS E PATOLOGICAS; CAMUNDONGOS TRANSGENICOS; HUMANOS; MUTACOES; CANCER; FAMILIA TTSP |
| 182/356 | US=7 / Farmacologia Wells BG, DiPiro JT, Schwinghammer TL, DiPiro Cecily V. Human immunodeficiency virus/acquired immune deficiency syndrome. In: ___. Pharmacotherapy handbook. 7th ed. New York: McGraw-Hill, 2008. p. 435-49. ISBN 978-0-07-148501-2. VIRUS DA IMUNODEFICIENCIA HUMANA; SINDROMA DE IMUNODEFICIENCIA ADQUIRIDA; VIRUS DA IMUNODEFICIENCIA HUMANA. TRANSMISSAO |
| 183/356 | US=8 / Dermatologia Gigli I. Human complement system. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 335-43. ISBN 978-0-07138076-0. SISTEMA COMPLEMENTO HUMANO; BIOQUIMICA DAS PROTEINAS DO COMPLEMENTO; MECANISMOS DE ATIVACAO; MECANISMOS DE REGULACAO; ATIVIDADE BIOLOGICA |
| 184/356 | US=80 / Biol/Mol Apweiler R, Mueller M. Bioinformatics and regulatory aspects of proteomics: annotating the human proteome. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 211-35. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. HUMANO; PROTEOMICA; ANOTACAO FUNCIONAL; INTEGRACAO DE DADOS; PADRONIZACAO DE DADOS |
| 185/356 | US=84 / Biol/Mol MacLaughlin DT, Donahoe PK. TGF-B superfamily members in normal and tumor biology: mullerian inhibiting substance: a potencial nontoxic, naturally occurring therapeutic agent for certain human cancers. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 333-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 186/356 | US=84 / Biol/Mol Fonsatti E, Maio M. TGF-B superfamily members in normal and tumor biology: endoglin (CD105): a strong candidate for immunologic targeting of tumor neovasculature in human malignancies. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 395-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ENDOGLINA; CD105; ANGIOGENESE; CARCINOGENESE; CELULAS ENDOTELIAIS; VASCULAR ALVO |
| 187/356 | US=84-A / Biol/Mol Weber SM, Lu SL, Bernstein S, Wang XJ. Transformig growth factor-B in developing and advanced cancers: role of transforming growth factor-B in the pathogenesis of human head and neck squamous cell carcinoma. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 21-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; CARCINOMA DE CELULAS ESCAMOSAS. CABECA E PESCOCO; TRANSGENICA RATO; RATO KNOCKOUT |
| 188/356 | US=84-A / Biol/Mol Korc M. Transformig growth factor-B in developing and advanced cancers: Aberrant growth factor-B signaling in human pancreatic cancer: translational implications. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 523-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. SMAD7; TGF-BS; AUTODRINE; ANGIOGENESE; CANCER DE PANCREAS; ALVOS TERAPEUTICOS |
| 189/356 | US=84-A / Biol/Mol Bandyópadhyay A, Sun L. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble TGF-B type III receptor suppresses malignant progression of human cancer cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 723-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ANGIOGENESE; METALOPROTEINASE DE MATRIZ-9; METASTASE PULMONAR; METASTASE OSSEA; BETAGLICAM SOLUVEL; TGF-B; TGF-B TIPO DE INIBIDORES DO RECEPTOR III; TUMORIGENESE |
| 190/356 | US=8-A / Dermatologia Tsao S. Human herpesvirus 6 and 7 infections and exanthem subitum (roseola infantum or sixth disease). In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 2099-103. ISBN 978-0-07-138076-0. HERPESVIRUS HUMANO 6; HERPESVIRUS HUMANO 7; EXANTEMA SUBITO; ROSEOLA INFANTUM; SEXTA DOENCA |
| 191/356 | US=8-A / Dermatologia Tschachler E, Reitz Junior MS, Franchini G. Human retroviral disease: human T-lymphotropic viruses. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 2131-7. ISBN 978-0-07-138076-0. DOENCA RETROVIRAL HUMANA; VIRUS LINFOTROPICO DA CELULA HUMANA; HTLV |
| 192/356 | US=8-A / Dermatologia Johnson RA. Cutaneous manifestations of human immunodeficiency virus disease. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 2138-50. ISBN 978-0-07-138076-0. VIRUS DA IMUNODEFICIENCIA; HIV; MANIFESTACOES CUTANEAS; SINDROME RETROVIRAL AGUDA; TERAPIA ANTI-RETROVIRAL; TERAPIA ANTIRETROVIRAL ALTAMENTE ATIVA |
| 193/356 | US=90 / Biol/Mol Bennett HL, Brummer T, Timpson P, Patterson KI, Daly RJ. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: signaling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 235-55. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. SRC; RAS; RAF; ERK; PI3-QUINASE; PTEN; EGFR INIBIDORES; LOOPS DE FEEDBACK; C-CBL; ENDOCITOSE |
| 194/356 | US=98 / Biol/Mol DiMaio D, Johung K, Goodwin EC, Horner SM, Yates KE. Senescence induced by repression of human papillomavirus oncogenes in cervical cancer cells. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 209-222. ISBN 978-084939192-7. SENESCENCIA INDUZIDA; REPRESSAO DOS ONCOGENES; CELULAS DE CANCER DO COLO DO UTERO. PAPILOMAVIRUS HUMANO |
| 195/356 | US=7 / Transplante Scharp DW. Cell therapy for peripheral diseases and reconstructive applications: encapsulated human islet allografts: providing safety with efficacy. In: Halberstadt C, Emerich D, editors. Cellular transplantation: from laboratory to clinic. Amsterdam: Elsevier, 2007. p. 135-53. ISBN 978-0-12-369415-7. TERAPIA CELULAR; DOENCAS PERIFERICAS; APLICACOES RECONSTRUTIVAS; ILHOTAS HUMANAS; ALOENXERTOS ENCAPSULADOS; TRANSPLANTE DE ILHOTAS CLINICAS; IMUNOSSUPRESSAO; MACROCAPSULAS; MICROCAPSULAS; REVESTIMENTOS ISOLANTES; ENSAIOS CLINICOS; BIOCOMPATIBILIDADE; ESTUDOS EM PEQUENOS ANIMAIS |
| 196/356 | US=111 / Câncer Talukdar S, Herrington CS. Human DNA tumour viruses. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 111-22. ISBN 978-0-470-01852-1. CANCER; VIRUS TUMORAIS; DNA HUMANOS; CARCINOGENESE; INFECCAO POR PAPILOMAVIRUS HUMANO; HPV; VIRUS DA HEPATITE B; HBV; VIRUS EPSTEIN-BARR; EBV; HERPESVIRUS HUMANO 8; SARCOMA DE KAPOSI; VIRUS SIMIO 40; VACINA |
| 197/356 | US=7 / Transplante Freed WJ, Sanchez JF, Lee CT, Vazin T, Amable R, Schoen C, Schwartz C, Rao M, Zeng X. Cell therapy for CNS diseases: human embryonic stem cells, dopaminergic neurons, and pathways for developing a Parkinson´s disease therapy. In: Halberstadt C, Emerich D, editors. Cellular transplantation: from laboratory to clinic. Amsterdam: Elsevier, 2007. p. 523-44. ISBN 978-0-12-369415-7. TERAPIA CELULAR; DOENCAS DO SISTEMA NERVOSO CENTRAL; CELULAS ESTAMINAIS EMBRIONARIAS HUMANAS; NEURONIOS DOPAMINERGICOS; DOENCA DE PARKINSON |
| 198/356 | US=111-A / Câncer Clarke R, Haier J. Human tumours in animal hosts. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 926-35. ISBN 978-0-470-01852-1. CANCER; PESQUISA DO CANCER; EXPERIMENTACAO ANIMAL; TUMORES HUMANOS; HOSPEDEIROS ANIMAIS |
| 199/356 | US=111-A / Câncer Koschmieder S, Serve HL. Models for human leukaemias. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 1145-53. ISBN 978-0-470-01852-1. CANCER; MODELOS PARA LEUCEMIA; TRANSPLANTE DE CELULAS LEUCEMICAS; TRANSDUCAO RETROVIRAL |
| 200/356 | US=16 / Urologia Corey E, Vessella RL. Biology and imaging: xenograft models of human prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 3-31. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. CANCER DE PROSTATA; BIOLOGIA; IMAGEM; MODELOS XENOENXERTO; ABLACAO ANDROGENICA; INDEPENDENCIA DE ANDROGENO; METASTASES OSSEAS; METASTASES; XENOENXERTOS |